R2 Technology has introduced at the RSNA meeting its new dual-mode ImageChecker, a single computer-aided detection unit that can process analog and digital mammography images simultaneously.
R2 Technology has introduced at the RSNA meeting its new dual-mode ImageChecker, a single computer-aided detection unit that can process analog and digital mammography images simultaneously.
The company also features at its booth standard mammography software that allows radiologists to compare last year's analog images with this year's digital ones. The software, obtained through an exclusive arrangement with Mirada, processes both types of images with the same set of software tools.
"By introducing software capability that takes two different renderings, two different analog and digital exposure parameters, and normalizes them to look like one another, we're trying to accelerate and embrace the movement toward digital and help individual facilities make the transition from analog to digital technology," said R2 CEO Mike Klein.
The software takes previously acquired analog images, which may appear grainy and fuzzy, and makes them look as if they had been captured using the latest digital acquisition format by smoothing out the borders of the breast, examining the physical properties of the breast, and taking a statistical sampling of the density of the breast.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
Mammography-Based AI Abnormality Scoring May Improve Prediction of Invasive Upgrade of DCIS
April 9th 2024Emerging research suggests that an artificial intelligence (AI) score of 75 or greater for mammography abnormalities more than doubles the likelihood of invasive upgrade of ductal carcinoma in situ (DCIS) diagnosed with percutaneous biopsy.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.